Unmasking the elusive: an early gestational age placenta accreta case series to illuminate the path towards avoiding missed diagnosis
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20232183Keywords:
Placenta accreta, Misdiagnosis, Early gestational ageAbstract
Placenta accreta is a condition characterized by the abnormal invasion of the placenta into the uterine wall, leading to torrential hemorrhage. This case series, highlights the importance of accurate diagnosis and early detection of this life-threatening complication. The incidence of this iatrogenic complication is rising due to increased caesarean deliveries. While in advance stages of pregnancy the chances of missing accreta are less but in early pregnancy the diagnosis may be elusive. Timely detection by using imaging modalities like ultrasound both 2D and colour Doppler, provide valuable clues. Misdiagnosis may be fatal, especially in the first trimester. The present case series presents 3 cases where initial diagnosis of missed abortion followed by repeated curettage and gestational trophoblastic disease (GTD) was made respectively. The agony of suffering leads the patient to our tertiary care center where the diagnosis of accreta was made. Accurate diagnosis and early detection of placenta accreta are vital to optimize patient outcome. Detecting the nicheand an anteriorly situated low lying placenta with history of previous birth by caesarian section should raise suspicion, and vigilance on the part of treating obstetrician is must.
References
Morlando M, Collins S. Placenta Accreta Spectrum Disorders: Challenges, Risks, and Management Strategies. Int J Womens Health. 2020;12:1033-45.
Fitzpatrick KE, Sellers S, Spark P, Kurinczuk JJ, Brocklehurst P, Knight M. Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study. PLoS One. 2012;7(12):e52893.
Piñas Carrillo A, Chandraharan E. Placenta accreta spectrum: Risk factors, diagnosis and management with special reference to the Triple P procedure. Womens Health (Lond). 2019;15:1745506519878081.
WHO Recommendations on Antenatal Care for a Positive Pregnancy Experience: Ultrasound Examination Highlights and Key Messages from the World Health Organization’s 2016 Global Recommendations. 2018. Available at: https://www.who.int/publications/i/item/9789241549912. Accessed on 09 April 2023.
Purbadi S, Tjahjadi H, Purwoto G, Kusuma F, Winarto H, Utami TW, et al. Early Gestational Age Placenta Accreta Case Report: Can We Avoid Missed Diagnosis? Am J Case Rep. 2021;22:e934168.
Dhanda S, Ramani S, Thakur M. Gestational trophoblastic disease: a multimodality imaging approach with impact on diagnosis and management. Radiol Res Pract. 2014;842751.
American College of Obstetricians and Gynecologists; Society for Maternal-Fetal Medicine. Obstetric Care Consensus No. 7: Placenta Accreta Spectrum. Obstet Gynecol. 2018;132(6):e259-75.
Fratelli N, Fichera A, Prefumo F. An update of diagnostic efficacy of ultrasound and magnetic resonance imaging in the diagnosis of clinically significant placenta accreta spectrum disorders. Curr Opin Obstet Gynecol. 2022;34(5):287-91.
Cheung CS, Chan BC. The sonographic appearance and obstetric management of placenta accrete. Int J Women's Health. 2012;4:587-94.
Matsubara S, Takahashi H, Takei Y. Magnetic resonance imaging for diagnosis of placenta accreta spectrum disorders: still useful for real‐world practice. Am J Obstet Gynecol. 2018;219:312‐3.
Aguilera M, Rauk P, Ghebre R, Ramin K. Complete hydatidiform mole presenting as a placenta accreta in a twin pregnancy with a coexisting normal fetus: case report. Case Rep Obstet Gynecol. 2012;405085.
